Literature DB >> 15952441

Evaluation and prevention of diabetic neuropathy.

Ann M Aring1, David E Jones, James M Falko.   

Abstract

Diabetic neuropathy is a debilitating disorder that occurs in nearly 50 percent of patients with diabetes. It is a late finding in type 1 diabetes but can be an early finding in type 2 diabetes. The primary types of diabetic neuropathy are sensorimotor and autonomic. Patients may present with only one type of diabetic neuropathy or may develop combinations of neuropathies (e.g., distal symmetric polyneuropathy and autonomic neuropathy). Distal symmetric polyneuropathy is the most common form of diabetic neuropathy. Diabetic neuropathy also can cause motor deficits, silent cardiac ischemia, orthostatic hypotension, vasomotor instability, hyperhidrosis, gastroparesis, bladder dysfunction, and sexual dysfunction. Strict glycemic control and good daily foot care are key to preventing complications of diabetic neuropathy.

Entities:  

Mesh:

Year:  2005        PMID: 15952441

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  36 in total

Review 1.  Potential targets for intervention in radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

Review 2.  Which Patient-Related Factors Determine Optimal Bowel Preparation?

Authors:  Myriam Martel; Charles Ménard; Sophie Restellini; Omar Kherad; Majid Almadi; Maïté Bouchard; Alan N Barkun
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 3.  [Influence of neurological diseases on partnership and sexuality. Particularly in view of multiple sclerosis and Parkinson's disease].

Authors:  D Goecker; D Rösing; K M Beier
Journal:  Urologe A       Date:  2006-08       Impact factor: 0.639

4.  Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.

Authors:  A Comunello; F Dassie; C Martini; E De Carlo; R Mioni; M Battocchio; A Paoletta; F Fallo; R Vettor; P Maffei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

5.  Autonomic mechanisms and therapeutic implications of postural diabetic cardiovascular abnormalities.

Authors:  Rohit R Arora; Robert J Bulgarelli; Samanwoy Ghosh-Dastidar; Joseph Colombo
Journal:  J Diabetes Sci Technol       Date:  2008-07

6.  The effect of Neuragen PN on neuropathic pain: A randomized, double blind, placebo controlled clinical trial.

Authors:  Li Li
Journal:  BMC Complement Altern Med       Date:  2010-05-20       Impact factor: 3.659

7.  High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes.

Authors:  Chloe M Stenkamp-Strahm; Adam J Kappmeyer; Joe T Schmalz; Martin Gericke; Onesmo Balemba
Journal:  Cell Tissue Res       Date:  2013-07-24       Impact factor: 5.249

8.  The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort.

Authors:  G Pambianco; T Costacou; Elsa Strotmeyer; T J Orchard
Journal:  Diabetes Res Clin Pract       Date:  2011-03-15       Impact factor: 5.602

9.  Predictive clinical factors of chronic peripheral neuropathy induced by oxaliplatin.

Authors:  Nilgun Yildirim; Mahir Cengiz
Journal:  Support Care Cancer       Date:  2020-01-23       Impact factor: 3.603

10.  Constipation, hard stools, fecal urgency, and incomplete evacuation, but not diarrhea is associated with diabetes and its related factors.

Authors:  Noriko Ihana-Sugiyama; Naoyoshi Nagata; Ritsuko Yamamoto-Honda; Eiko Izawa; Hiroshi Kajio; Takuro Shimbo; Masafumi Kakei; Naomi Uemura; Junichi Akiyama; Mitsuhiko Noda
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.